Toxicity of dose-escalated, hypofractionated helical tomotherapy for inoperable thoracic esophageal squamous cell carcinoma

Table 1 Baseline patient and tumor characteristics

Characteristics	Median (range)	n	%
Sex
Man		41	87.2
Woman		6	12.8
Age, years,	61 (36-86)
Location of tumor
Upper		11	23.4
Middle		17	36.2
Lower		19	40.4
Tumor classification
T3		18	38.3
T4A		7	14.9
T4B		22	46.8
Lymph node status
N0		2	4.3
N1		24	51.1
N2		21	44.7
Disease stage
IIIa		5	10.6
IIIb		13	27.7
IIIc		29	61.7
TP chemotherapy
0		18	38.3
1		4	8.5
2		12	25.5
4		13	27.7

TP: Docetaxel + cisplatin.